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The pro-inflammatory and chemotactic cytokine
microenvironment of the abdominal aortic
aneurysm wall: A protein array study
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Nicola J. Cooper, PhD,b Nicholas J. London, MD,a and Robert D. Sayers, MD,a Leicester, UK
Objective: Cytokines are inflammatory mediators implicated in abdominal aortic aneurysm (AAA) pathogenesis. The
cytokine expression profile of the AAA is poorly defined and has focused on the expression of pro-inflammatory cytokines,
at the expense of chemokines and growth factors. This study aims to investigate the cytokine expression profile of the
established AAA wall.
Methods: Cytokine protein expression was measured in homogenized human aortic tissue (10 AAAs and 9 nonaneurysmal
controls) using a 42-cytokine antibody-based protein array. Data were quantified using densitometric analysis and
statistically analyzed using a Mann-Whitney U test.
Results:A significant difference in cytokine expression between AAA and control samples was found in 15 of 42 cytokines.
Several pro-inflammatory cytokines were upregulated within the AAA compared with the control: interleukin (IL)-6 (P
 .001), IL-1 (P  .001), IL-1 (P < .001), tumor necrosis factor (TNF)- (P  .002), TNF- (P  .002), and
oncostatin M (P  .007). The anti-inflammatory cytokine IL-10 was also upregulated (P  .002). Members of the
chemokine family were also highly expressed within AAA samples: IL-8 (P  .001), epithelial neutrophil-activating
peptide-78 (ENA-78; P  .006), growth related oncogene (GRO; P < .001), monocyte chemoattractant protein
(MCP)-1 (P .003),MCP-2 (P< .001), and regulated upon activation, normal T-cell expressed and secreted (RANTES;
P  .001). Of the growth factors examined, granulocyte colony-stimulating factor (GCSF; P  .003) and macrophage
colony-stimulating factor (MCSF; P  .004) were significantly higher in the AAA.
Conclusions: The established AAA is characterized by a distinct cytokine profile consisting of pro-inflammatory cytokines,
chemokines, and specific growth factors. This suggests that these cytokines may contribute to pathologic changes within
the established, preruptured aneurysm. (J Vasc Surg 2007;45:574-80.)
Clinical Relevance: Through the screening of the expression of 42 cytokines within the wall of large abdominal aortic
aneurysms (>55 mm diameter), this study has identified a number of pro-inflammatory cytokines, chemokines, and
growth factors that are raised within the aneurysm wall. This suggests that pathways involving these cytokines may be
involved in aneurysm development. This study contributes to the collective understanding of the pathologic changes in
the abdominal aortic aneurysmwall that may ultimately lead to the development of a nonsurgical therapeutic intervention
to stabilize the abdominal aortic aneurysm, prevent further growth, and aneurysm rupture.The precise pathogenesis of the abdominal aortic aneu-
rysm (AAA) is unknown but is thought to be multifactorial,
with significant environmental and genetic contributions.
Themechanisms involved in AAA formation are proteolytic
degradation, biomechanical wall stress, and inflammation.1
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574The AAA wall is characterized by a loss of elastin,
increased collagenmetabolism, smoothmuscle cell apopto-
sis, and a chronic inflammatory infiltrate.2-4 The predomi-
nant inflammatory cells present within the wall are lympho-
cytes and macrophages.4,5 These inflammatory cells have a
role in AAA pathogenesis through secretion and activation
of matrix metalloproteinases (MMPs),6,7 which degrade
the extracellular matrix and weaken the aortic wall. The
expression of MMPs and tissue inhibitors of metallopro-
teinases (TIMPs) is in part controlled at the transcription
level by the action of cytokines.8,9
Cytokines are intercellular messenger proteins involved
in the regulation of the immune system and are important
in inflammation, hematopoiesis, cellular and humoral re-
sponses, and wound healing. Chemokines represent a su-
perfamily of cytokines that function as potent chemoattrac-
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of cytokines in AAA pathogenesis has been highlighted
through animal models. Blocking the action of tumor
necrosis factor- (TNF-) protected against aneurysm for-
mation in the elastase-induced rat model.10 Likewise, CD4,
interferon- (IFN-) double knockout mice did not de-
velop aneurysms in an AAA murine model, but upon ad-
ministration of IFN- aneurysm development was partially
reconstituted.11
The main cellular sources of cytokines are TH-lymphocytes
and macrophages. The chronic inflammatory nature of the
AAA wall is therefore a potentially cytokine-enriched envi-
ronment. Specific cytokines have been described within
the AAA wall, including interleukin-1 (IL-1), IL-6,
and TNF- . 12-15 However, many reports of cytokine
expression within the AAA wall are contradictory, with
some reports suggesting the expression of a TH1 re-
sponse11,16,17 (with the secretion of pro-inflammatory cy-
tokines), whereas others support the dominant expression
of a TH2 response
18-20 (with the secretion of anti-inflam-
matory cytokines).
It is difficult to obtain an overview of cytokine expres-
sion within the AAA because the variations in study design
make it impossible to compare across the studies. In addi-
tion, the use of techniques such as enzyme-linked immu-
nosorbent assays, Western blotting, and reverse transcrip-
tase polymerase chain reaction only allow the study of a
limited repertoire of cytokines and require the selection of
candidate cytokines by the investigator. This can miss
novel, unanticipated changes in the cytokine profile.
Arrays are an alternative that provide a useful tool for
the rapid screening of a large number of potential candidate
proteins/genes and increase the chance of identifying a
clinically relevant change in protein/messenger RNA
(mRNA) expression. Gene arrays have been used to analyze
the expression of multiple genes within the AAA, including
those involved in inflammation.21,22 These studies, how-
ever, do not specifically provide a comprehensive overview
of the expression of cytokines within the human aneurysm
wall. In addition, although complimentary DNA (cDNA)
arrays provide useful information on gene expression,
mRNA expression does not always correlate with protein
expression. Because proteins are the effector molecules, the
protein expression profile is physiologically more relevant.
To our knowledge, no comprehensive description of
the cytokine profile within the AAA wall has been per-
formed to date. The aim of the study was to determine the
cytokine expression profile of the large AAA wall through
the use of a 42-cytokine protein array. This study tested the
hypothesis that AAAs are characterized by a large, inflam-
matory, chemotactic cytokine profile.
METHODS
Study design. Full thickness AAAwall specimens were
obtained from the anterior wall at the point of maximal
aortic dilation during elective open AAA repair of asymp-
tomatic AAAs. Aneurysm biopsies were taken as soon as the
sac was opened, once hemostasis had been achieved. Ad-herent thrombus was removed manually at the time of
surgery.
Samples were acquired from 10 infrarenal, atheroscle-
rotic aneurysms. The median patient age was 73 years
(range, 67 to 81 years), all were men, and 80% had a
smoking history. The median AAA diameter was 75 mm
(range, 56 to 93 mm). All aneurysms were sporadic, with
no reported family history, and had not shown a sudden
increase in size since diagnosis. Patients with inflammatory
AAAs or evidence of retroperitoneal fibrosis, or symptom-
atic or ruptured AAAs were excluded.
The control group comprised nine nonaneurysmal ab-
dominal aortic specimens obtained from aortic patches
from cadaveric kidney donors provided by the UK Human
Tissue Bank in Leicester, United Kingdom. The patients
were a median age of 55 years (range, 44 to 74 years), six
were men, and 89% had a smoking history. The causes of
death for the donors were related to intracerebral hemor-
rhages or cardiac arrest/brain hypoxia. At the point of
harvesting, the specimens were snap frozen in liquid nitro-
gen and stored at 80°C for batch analysis. Studies were
performed with the approval of the Leicestershire Research
Ethics Committee, and written consent was obtained from
all participants or next of kin.
Aorta homogenization. Aortic specimens were quar-
tered and washed in phosphate-buffered saline, pH 7.45,
for 20 minutes at 4°C to remove blood. The quarters from
each specimen were recombined and homogenized. Tissue
was homogenized using an Ultra-Turrax T-25 homoge-
nizer (IKA Labortechnik, Staufen, Germany) in a 1 cell
lysis buffer provided with the Human Cytokine Protein
Array 3.1 (RayBiotech, Inc, Norcross, Ga), supplemented
with 1 Complete, Mini Protease Inhibitor Cocktail
(Roche Diagnostics GmbH, Mannheim, Germany). The
homogenates were sonicated for 3  10 seconds, 12 m
amplitude, in a Soniprep 150 sonicator (Sanyo, Watford,
UK). Cellular debris was removed by centrifugation for 1
hour at 14,000 rpm at 4°C.
Bicinchoninic acid protein assay. Protein concentra-
tion of the homogenates’ supernatant was determined us-
ing a bicinchoninic acid protein assay method, according to
manufacturer’s instructions, (Pierce, Rockford, Ill), and all
homogenates were manipulated to an equal total protein
concentration.
Cytokine protein array. The Human Cytokine Pro-
tein Array 3.1 kit, an antibody-based array, was used to
simultaneously detect 42 cytokines in each homogenized
sample according to the manufacturer’s instructions. Briefly,
array membranes were incubated overnight at 4°C in a 1
blocking buffer (all reagents were supplied with the array
kit). The tissue lysates were then incubated on the mem-
branes for 2 hours.
All of the following steps were performed at room
temperature, and all wash stages involved three washes in
wash buffer I for 5 minutes each, followed by two washes in
wash buffer II for 5 minutes each. The biotinylated anti-
human cytokinemix of antibodies (1:250) was added to the
membranes and incubated for 2 hours. Membranes were
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radish peroxidase (1:1000) for 1 hour. Unbound reagents
were removed by washing, and the membranes were incu-
bated in detection buffer for 1 minute.
The chemiluminescent signal from the bound cyto-
kines was detected on Kodak BioMax Light film (Sigma,
Poole, UK). Cytokine signal intensity was measured by
spot densitometry using an AlphaImager 1220 Analysis and
Documentation System (Alpha Innotech, Braintree, UK).
Each spot was corrected for adjacent background intensity
and normalized to the membrane’s positive control. Each
specimen was measured in duplicate, and the mean signal
intensity value for each cytokine within a specimen was
determined. The overall expression of each specific cyto-
kine in the AAA and control groups was expressed as the
median signal intensity value (interquartile range).
Statistical analysis. All analyses were performed with
SPSS 11.0 software (SPSS Inc, Chicago, Ill). The data for
each cytokine were compared usingMann-WhitneyU tests.
Because of the multiple testing, a value of P .01 was used
to identify any statistically significant differences.
RESULTS
We found that 15 of 42 cytokines were significantly
different between the AAA and the control samples. Figs 1,
2, and 3 display box plots of all 42 cytokines and highlight
those that were significantly different (Mann-Whitney, P
.01). The data for each cytokine are presented as AAA
median signal intensity value (interquartile range) vs con-
trol median signal intensity value (interquartile range).
CXC chemokines. Fig 1, A shows the expression of
the chemokines on the array that belonged to the CXC
subfamily. IL-8 was significantly higher in the AAA than in
the control (0.68 [0.49 to 0.80] vs 0.16 [0.14 to 0.31],
P  .001) and was the most highly expressed cytokine in
the AAA of the 42 cytokines examined. The other statisti-
cally significant CXC chemokines were epithelial neutro-
phil activating peptide-78 (ENA-78) and growth related
oncogene (GRO), which were expressed in the AAA but
were not expressed within the controls (ENA-78: 0.09
[0.00 to 0.12] vs 0.00 [0.00 to 0.00], P  .006; GRO:
0.10 [0.09 to 0.14] vs 0.00 [0.00 to 0.01], P  .001).
GRO-, monokine-induced by interferon- (MIG), and
stromal cell derived factor-1 (SDF-1) were rarely expressed
in either the AAA or control (GRO-: 0.00 [0.00 to 0.01]
vs 0.00 [0.00 to 0.00], P .083;MIG: 0.00 [0.00 to 0.00]
vs 0.00 [0.00 to 0.00], P  .909; SDF-1: 0.01 [0.00 to
0.02] vs 0.01 [0.00 to 0.02], P  .967).
CC chemokines. The CC chemokines on the array are
shown in Fig 1, B. Monocyte chemoattractant protein-1
(MCP-1), MCP-2, and RANTES (regulated upon activa-
tion, normal T-cell expressed and secreted) were signifi-
cantly higher in the AAA samples than in the control
(MCP-1: 0.41 [0.20 to 0.48] vs 0.03 [0.00 to 0.25], P 
.003; MCP-2: 0.14 [0.13 to 0.18] vs 0.00 [0.00 to
0.05], P  .001; RANTES: 0.18 [0.11 to 0.23] vs 0.02
[0.00 to 0.05], P  .001). MCP-2 was expressed withinthe AAA but was negligibly expressed within the control.
I-309 was not detected in either the AAA or control
(0.00 [0.00 to 0.00] vs 0.00 [0.00 to 0.00], P  .343).
MCP-3, macrophage-derived chemokine (MDC), macro-
phage inflammatory protein-1	 (MIP-1	), and thymus and
activation-regulated chemokine (TARC) were not signifi-
cantly different between groups (MCP-3: 0.01 [0.00 to
Fig 1. Box plots show the expression of the (A)CXC chemokines
(ENA-78, epithelial neutrophil activating peptide-78; GRO,
growth regulated oncogene; IL-8, interleukin-8; MIG, monokine-
induced by interferon-; SDF-1, stromal cell derived factor-1) and
(B) the CC chemokines (MCP, monocyte chemoattractant pro-
tein; MDC, macrophage-derived chemokine; MIP-1	, macro-
phage inflammatory protein-1	; RANTES, regulated upon activa-
tion, normal T-cell expressed and secreted; TARC, thymus and
activation-regulated chemokine). The interquartile range (box)
and median (internal bar within the box) signal intensity values in
abdominal aortic aneurysm (AAA) (n  10) and control (n  9)
samples are displayed for each cytokine. The whiskers display the
range of values. Mann-Whitney analysis was performed for each
cytokine and the results with a significant P value (P  .01) are
displayed on the graph.0.03] vs 0.00 [0.00 to 0.03], P  .546; MDC: 0.00 [0.00
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[0.00 to 0.03] vs 0.00 [0.00 to 0.02], P  .251; TARC:
0.00 [0.00 to 0.01] vs 0.00 [0.00 to 0.00], P  .235).
Pro-inflammatory cytokines. Of the eight proin-
flammatory cytokines examined (Fig 2, A), IL-6 was the
most highly expressed within the AAA and was 15-fold
higher in the AAA compared with the control (0.15 [0.08
to 0.23] vs 0.01 [0.00 to 0.02], P .001). The others that
were significantly higher in the AAA were IL-1 (0.07
[0.04 to 0.09] vs 0.00 [0.00 to 0.00], P  .001), IL-1
(0.04 [0.03 to 0.07] vs 0.00 [0.00 to 0.00], P  .001),
*P values could not be reported as there was little expression to compare and
Fig 2. Box plots show the expression of the (A) pro-inflamma-
tory (IL, interleukin; IFN-, interferon-; TNF, tumor necrosis
factor; OSM, oncostatin M) and (B) anti-inflammatory cytokines
(IL, interleukin). The interquartile range (box) and median (inter-
nal bar within the box) signal intensity values in abdominal aortic
aneurysm (AAA) (n  10) and control (n  9) samples are
displayed for each cytokine. The whiskers display the range of
values. Mann-Whitney analysis was performed for each cytokine
and the results with a significant P value (P .01) are displayed on
the graph.statistical analysis was not appropriate.TNF- (0.06 [0.03 to 0.09] vs 0.00 [0.00 to 0.01], P 
.002), TNF- (0.07 [0.04 to 0.08] vs 0.02 [0.01 to 0.04],
P .002) and oncostatinM (OSM) (0.06 [0.03 to 0.07] vs
0.01 [0.00 to 0.02], P .007). Overall, IL-1, IL-1, and
TNF- were not detected in the control. IL-12 and IFN-
showed a higher median expression within the AAA than in
the control (IL-12: 0.04 [0.01 to 0.07] vs 0.00 [0.00 to
0.04], P .017; IFN-: 0.06 [0.00 to 0.08] vs 0.00 [0.00
Fig 3. A and B, The expression of the growth factors from the
arrays are shown in the box plots. The interquartile range (box)
and median (internal bar within the box) signal intensity values in
abdominal aortic aneurysm (AAA) (n  10) and control (n  9)
samples are displayed for each cytokine. The whiskers display the
range of values. Mann-Whitney analysis was performed for each
cytokine and the results with a significant P value (P  .01) are
displayed on the graph (GCSF, granulocyte colony-stimulating
factor; GM-CSF, granulocyte/macrophage colony-stimulating
factor; MCSF, macrophage colony-stimulating factor; SCF, stem
cell factor; VEGF, vascular endothelial growth factor; PDGF-,
platelet-derived growth factor-; EGF, epidermal growth factor;
IGF-1, insulin-like growth factor-1; TGF-1, transforming growth
factor-1; IL, interleukin; Ang, angiogenin; Tpo, thrombopoietin).to 0.00], P .012). However, based on a significance level
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between the AAA and the control.
Anti-inflammatory cytokines. The anti-inflammatory
cytokines are shown in Fig 2, B. IL-4 and IL-13 were
undetectable in both groups (IL-4: 0.00 [0.00 to 0.00] vs
0.00 [0.00 to 0.00], P  .878; IL-13: 0.00 [0.00 to 0.00]
vs 0.00 [0.00 to 0.00], P  N/A*. IL-10 was expressed
within the AAA but not in the control (0.12 [0.04 to 0.14]
vs 0.00 [0.00 to 0.00], P  .002).
Growth factors. The remaining cytokines on the ar-
rays are growth factors (Fig 3). The only growth factors
that were significantly different between the AAA group
and the controls were granulocyte colony-stimulating fac-
tor (GCSF) and macrophage colony-stimulating factor
(MCSF), which were significantly higher in the AAA
(GCSF: 0.02 [0.01 to 0.03] vs 0.00 [0.00 to 0.00], P 
.003; MCSF: 0.08 [0.04 to 0.10] vs 0.01 [0.00 to 0.02],
P  .004; Fig 3, A). Angiogenin was the most highly
expressed growth factor in aortic tissue and was consistently
expressed on every AAA array; however, it was not signifi-
cantly different between AAA tissue and the control (0.50
[0.41 to 0.60] vs 0.82 [0.17 to 0.98], P  .624; Fig 3, B).
Several other growth factors were expressed within
aortic tissue, but were not significantly different between
the AAA tissue and the control. These included vascular
endothelial growth factor (VEGF), platelet-derived growth
factor- (PDGF-), epidermal growth factor (EGF), and
thrombopoietin (VEGF: 0.05 [0.03 to 0.10] vs 0.03 [0.01
to 0.09], P  .462; PDGF-: 0.02 [0.00 to 0.04] vs 0.00
[0.00 to 0.00], P .122; EGF: 0.09 [0.08 to 0.17] vs 0.03
[0.02 to 0.07], P  .011; thrombopoietin: 0.04 [0.01 to
0.08] vs 0.04 [0.00 to 0.06], P  .362).
The remainder of the growth factors that were negligi-
bly expressed in aortic tissue were granulocyte/macro-
phage colony-stimulating factor (GM-CSF), stem cell fac-
tor (SCF), insulin-like growth factor-1 (IGF-1),
transforming growth factor-1 (TGF-1), leptin, IL-2,
IL-3, IL-5, IL-7, and IL-15 (GM-CSF: 0.00 [0.00 to 0.01]
vs 0.00 [0.00 to 0.00], P .083; SCF: 0.01 [0.00 to 0.05]
vs 0.00 [0.00 to 0.02], P  .317; IGF-1: 0.00 [0.00 to
0.01] vs 0.00 [0.00 to 0.00], P  .083; TGF-1: 0.00
[0.00 to 0.01] vs 0.00 [0.00 to 0.00], P  .360; leptin:
0.00 [0.00 to 0.01] vs 0.00 [0.00 to 0.00], P .083; IL-2:
0.01 [0.00 to 0.04] vs 0.00 [0.00 to 0.01], P .251; IL-3:
0.00 [0.00 to 0.03] vs 0.00 [0.00 to 0.00], P .120; IL-5:
0.00 [0.00 to 0.01] vs 0.00 [0.00 to 0.00], P  .083;
IL-7: 0.00 [0.00 to 0.00] vs 0.00 [0.00 to 0.00], P 
N/A*; IL-15: 0.00 [0.00 to 0.01] vs 0.00 [0.00 to 0.01],
P  .792.
DISCUSSION
The present study demonstrates that the AAA exhib-
its a distinct cytokine profile consisting of an upregula-
tion of pro-inflammatory cytokines, chemokines, and
specific growth factors. We studied the expression of 42
*P values could not be reported as there was little expression to compare and
statistical analysis was not appropriate.cytokines, 18 of which had not been investigated before in
AAAs, and found a significant difference in the expression
of 15 cytokines between the AAA and the control. Al-
though our study is supported by previous reports on the
expression of several of these cytokines, as far as we are
aware, this study is the first report of an upregulation of
ENA-78, GRO, MCP-2, GCSF, and MCSF within the
human AAA wall.
CXC chemokines. ENA-78, GRO, and IL-8 were
significantly higher in the AAA than in the control. ENA-
78, GRO, GRO-, and SDF-1 have not been studied in the
AAA before, but increased expression of IL-8 from AAA
explants has been described previously.23 In a study of
1176 gene products within the AAA wall, IL-8 was shown
to be upregulated 11-fold compared with normal cadaveric
organ donors.21 ENA-78, GRO, and IL-8 can bind to
CXCR1 and CXCR2 receptors. They act primarily on
neutrophils as chemoattractants and activators, inducing
neutrophil degranulation with the release of myeloperoxi-
dase and other enzymes, which may have detrimental ef-
fects on the extracellular matrix of the AAA.
CC chemokines. MCP-1, MCP-2, and RANTES
were significantly higher in the AAA than in the control.
Previous studies have shownMCP-1 to be released by AAA
explants in greater quantities than from occlusive or normal
aortas,23 and gene arrays have demonstrated a twofold
increase in RANTES expression within the AAA.21 I-309,
MCP-2, MDC, MIP-1	, and TARC have not been studied
previously in association with AAAs. An elastase-induced
aneurysmal mouse model demonstrated that MCP-1 and
RANTESwere upregulatedwithin the aneurysmal wall before
macrophage infiltration.24 A potential role for MCP-1 in
AAA formation is supported by a study on CCR2, the
receptor for MCP-1, where the deletion of the CCR2 gene
within apolipoprotein E (apoE) knockout mice suppressed
aneurysm formation when the mice were treated with an-
giotensin II.25 A previous study showed that IL-8 and
MCPs acted synergistically to achieve maximal neutrophil
migration at suboptimal IL-8 levels26; thus, it is possible
that the increased expression of both IL-8 and the MCPs
within the AAA wall may synergistically augment neutro-
phil chemotaxis into the AAA wall.
Pro-inflammatory cytokines. This study has shown a
significant increase in the expression of IL-1, IL-1,
TNF-, TNF-, oncostatin M, and IL-6 between the AAA
and control. This study’s findings agree with previous
reports that IL-1 is higher in the AAA than in abdominal
aorta from cadaveric organ donors.12,13 The expression of
IL-1 is potentially damaging to the AAA wall, as it has
been shown to induce the synthesis of inflammatory medi-
ators such as prostaglandin and MMPs, and decreases the
synthesis of type I collagen by smooth muscle cells.8,27
TNF-, a pleiotropic mediator of chronic inflammatory
and immune functions, has been widely studied within the
AAA and has been shown to be increased within the aneu-
rysm.13,15,28 Mural expression of oncostatin M has been
identified in the AAA through immunohistochemistry.29Administration of oncostatin M to mice causes an acute
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phonuclear leukocytes (PMN), increased adhesion mole-
cule expression, and the release of PMN activators IL-6,
ENA-78, GRO-, and GRO-.29 This mirrors the array’s
findings that oncostatin M was significantly higher in the
human AAA and was coexpressed with IL-6, ENA-78, and
GRO, which were all significantly higher in the AAA.
Many studies have reported that IL-6 is highly ex-
pressed within in the AAA14 with respect to control aorta30
or aortic occlusive disease.15 Rohde et al31 found that
serum IL-6 was positively associated with aortic diameter in
nonaneurysmal subjects and suggested that IL-6 may be
involved in the early phase of AAA formation. The upregu-
lated expression of these pro-inflammatory cytokines may
promote a general inflammatory state within the AAA wall,
with further cascades of cytokine secretion and an increased
release of proteolytic enzymes within the AAA wall.
Anti-inflammatory cytokines. IL-10 was also signif-
icantly upregulated within the AAA, results that agree with
previous studies.18,19 IL-13 has not been studied previ-
ously within the AAA. IL-10 can decrease the expression of
IL-1, TNF-, and IL-6.32 It has also been shown to
decrease MMP expression and induce TIMP-1 biosynthe-
sis.33 However, pro-inflammatory cytokines were increased
within the AAA despite the presence of IL-10.
Growth factors. Angiogenin was highly expressed
within aortic tissue, perhaps reflecting its role in angiogen-
esis. The growth factors GCSF, EGF, SCF, leptin, IL-3,
IL-7, angiogenin, and thrombopoietin had not been stud-
ied in AAAs before. GCSF andMCSFwere the only growth
factors significantly higher in the AAA than in the control.
These cytokines have not been studied previously within
the human AAA wall. GCSF and MCSF are growth, differ-
entiation, and activating factors for neutrophils or macro-
phages, respectively. Because activated neutrophils and
macrophages have the potential to release proteolytic en-
zymes, an increase in GCSF andMCSF expression in AAAs
may indirectly promote AAA wall degradation. The expres-
sion of these growth factors, coupled with the coexpression
of IL-8, MCP-1, and MCP-2, suggests that the inflamma-
tory cells, neutrophils, andmacrophages, may be important
in AAA development and could potentially be recruited
into the AAAwall where they could undergo differentiation
and activation.
Macrophages have been previously implicated in an-
eurysm formation through the secretion of MMPs.7,34,35
A recent study demonstrated that neutrophil depletion
prevented AAA formation in an elastase-induced murine
model.36 This complements this study’s findings that che-
mokines, pro-inflammatory cytokines, and growth factors
that target neutrophils are increased within the aneu-
rysm. This suggests that the neutrophil may be more
important in aneurysm development than had previously
been appreciated.
This study provides a descriptive analysis of the cyto-
kine expression profile in the established AAA. There are
several limitations to this study. Because the AAA speci-
mens are obtained once the AAA has attained an operablesize, it is therefore impossible to identify alterations in the
cytokine profile during the early stages of AAA develop-
ment. This limits the interpretation of the results to the
state of the developed aneurysm wall that is undergoing
expansion and is prerupture.
This study used homogenized full-thickness aneu-
rysm wall biopsy specimens to provide an overview of
cytokine expression within the AAA wall. However, a
more detailed analysis involving the dissection of the
layers of the aneurysm wall before homogenization may
identify small changes in regional cytokine expression that
may have been masked by analyzing the whole tissue.
Having identified cytokines for future research, func-
tional studies are required to determine their role in AAA
development.
CONCLUSION
This is the first study that we know of to investigate the
expression of 42 cytokine proteins within human AAAs,
several of which had not been studied before. It has de-
scribed the cytokine profile of the established AAA and has
highlighted the upregulation of several pro-inflammatory
cytokines, chemokines, and specific growth factors within
the AAA. The altered cytokine profile may result in patho-
logic changes within the established aneurysm wall that
may increase the susceptibility of the aneurysm to expan-
sion and rupture. These findings contribute to the under-
standing of the inflammatory environment within the es-
tablished AAA wall with the aim that future research may
ultimately lead to a therapeutic intervention to stabilize the
AAA to prevent further growth and aneurysm rupture.
AUTHOR CONTRIBUTIONS
Conception and design: RM, NL, RS
Analysis and interpretation: RM, MB, NC, RS
Data collection: RM, GL
Writing the article: RM
Critical revision of the article: GL, MB, NC, NL, RS
Final approval of the article: RM, GL, MB, NC, NL, RS
Statistical analysis: NC
Obtained funding: RS
Overall responsibility: RM
REFERENCES
1. Wassef M, Baxter BT, Chisholm RL, Dalman RL, Fillinger MF, Hei-
necke J, et al. Pathogenesis of abdominal aortic aneurysms: a multidis-
ciplinary research program supported by the National Heart, Lung, and
Blood Institute. J Vasc Surg 2001;34:730-8.
2. Carmo M, Colombo L, Bruno A, Corsi FR, Roncoroni L, Cuttin
MS, et al. Alteration of elastin, collagen and their cross-links in abdom-
inal aortic aneurysms. Eur J Vasc Endovasc Surg 2002;23:543-9.
3. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby
P. Death of smooth muscle cells and expression of mediators of apopto-
sis by T lymphocytes in human abdominal aortic aneurysms. Circulation
1999;99:96-104.
4. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson
PG, et al. Human abdominal aortic aneurysms. Immunophenotypic
analysis suggesting an immune-mediated response. Am J Pathol 1990;
137:1199-213.
JOURNAL OF VASCULAR SURGERY
March 2007580 Middleton et al5. Bobryshev YV, Lord RS. Vascular-associated lymphoid tissue (VALT)
involvement in aortic aneurysm. Atherosclerosis 2001;154:15-21.
6. McMillanWD, Patterson BK, Keen RR, PearceWH. In situ localization
and quantification of seventy-two-kilodalton type IV collagenase in
aneurysmal, occlusive, and normal aorta. J Vasc Surg 1995;22:295-305.
7. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD,
Mecham RP, et al. Production and localization of 92-kilodalton gelati-
nase in abdominal aortic aneurysms. An elastolytic metalloproteinase
expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:
318-26.
8. Keen RR, Nolan KD, Cipollone M, Scott E, Shively VP, Yao JS, et al.
Interleukin-1 beta induces differential gene expression in aortic smooth
muscle cells. J Vasc Surg 1994;20:774-84.
9. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine
modulation of trabecular meshwork matrix metalloproteinase and
TIMP expression. Curr Eye Res 1998;17:276-85.
10. Hingorani A, Ascher E, Scheinman M, Yorkovich W, DePippo P,
Ladoulis CT, et al. The effect of tumor necrosis factor binding protein
and interleukin-1 receptor antagonist on the development of abdominal
aortic aneurysms in a rat model. J Vasc Surg 1998;28:522-6.
11. Xiong W, Zhao Y, Prall A, Greiner TC, Baxter BT. Key roles of CD4

T cells and IFN-gamma in the development of abdominal aortic aneu-
rysms in a murine model. J Immunol 2004;172:2607-12.
12. Pearce WH, Sweis I, Yao JS, McCarthy WJ, Koch AE. Interleukin-1
beta and tumor necrosis factor-alpha release in normal and diseased
human infrarenal aortas. J Vasc Surg 1992;16:784-9.
13. Newman KM, Jean-Claude J, Li H, Ramey WG, TilsonMD. Cytokines
that activate proteolysis are increased in abdominal aortic aneurysms.
Circulation 1994;90:II224-7.
14. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries
SE, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic
aneurysms. Circulation 2001;103:2260-5.
15. Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, et al.
Abdominal aortic aneurysm and aortic occlusive disease: a comparison
of risk factors and inflammatory response. Eur J Vasc Endovasc Surg
2000;20:462-5.
16. Galle C, Schandene L, Stordeur P, Peignois Y, Ferreira J, Wautrecht JC,
et al. Predominance of type 1 CD4
 T cells in human abdominal aortic
aneurysm. Clin Exp Immunol 2005;142:519-27.
17. Szekanecz Z, Shah MR, Pearce WH, Koch AE. Human atherosclerotic
abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-
gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-
gamma in vascular inflammation. Agents Actions 1994;42:159-62.
18. Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG,
Baxter BT. Cytokine pattern in aneurysmal and occlusive disease of the
aorta. J Surg Res 2001;101:152-6.
19. Schonbeck U, Sukhova GK, Gerdes N, Libby P. T(H)2 predominant
immune responses prevail in human abdominal aortic aneurysm. Am J
Pathol 2002;161:499-506.
20. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN. Th2-
predominant inflammation and blockade of IFN-gamma signaling in-
duce aneurysms in allografted aortas. J Clin Invest 2004;114:300-8.
21. Tung WS, Lee JK, Thompson RW. Simultaneous analysis of 1176 gene
products in normal human aorta and abdominal aortic aneurysms using
a membrane-based complementary DNA expression array. J Vasc Surg
2001;34:143-50.22. Armstrong PJ, Johanning JM, CaltonWC Jr, Delatore JR, Franklin DP,
Han DC, et al. Differential gene expression in human abdominal aorta:
aneurysmal versus occlusive disease. J Vasc Surg 2002;35:346-55.
23. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL,
et al. Enhanced production of the chemotactic cytokines interleukin-8
and monocyte chemoattractant protein-1 in human abdominal aortic
aneurysms. Am J Pathol 1993;142:1423-31.
24. Colonnello JS, Hance KA, Shames ML, Wyble CW, Ziporin SJ, Lei-
denfrost JE, et al. Transient exposure to elastase induces mouse aortic
wall smooth muscle cell production of MCP-1 and RANTES during
development of experimental aortic aneurysm. J Vasc Surg 2003;
38:138-46.
25. Ishibashi M, Egashira K, Zhao Q, Hiasa K, Ohtani K, Ihara Y, et al.
Bone marrow-derived monocyte chemoattractant protein-1 receptor
CCR2 is critical in angiotensin II-induced acceleration of atherosclero-
sis and aneurysm formation in hypercholesterolemic mice. Arterioscler
Thromb Vasc Biol 2004;24:e174-8.
26. Gouwy M, Struyf S, Catusse J, Proost P, Van Damme J. Synergy
between proinflammatory ligands of G protein-coupled receptors in
neutrophil activation and migration. J Leukoc Biol 2004;76:185-94.
27. Evans CH, Georgescu HI, Lin CW, Mendelow D, Steed DL, Webster
MW. Inducible synthesis of collagenase and other neutral metallopro-
teinases by cells of aortic origin. J Surg Res 1991;51:399-404.
28. SatohH, NakamuraM, SatohM, Nakajima T, IzumotoH,Maesawa C,
et al. Expression and localization of tumour necrosis factor-alpha and its
converting enzyme in human abdominal aortic aneurysm. Clin Sci
(Lond) 2004;106:301-6.
29. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmer-
man GA, et al. Oncostatin M is a proinflammatory mediator. In vivo
effects correlate with endothelial cell expression of inflammatory cyto-
kines and adhesion molecules. J Clin Invest 1997;100:158-68.
30. Reilly JM, Miralles M, Wester WN, Sicard GA. Differential expression
of prostaglandin E2 and interleukin-6 in occlusive and aneurysmal
aortic disease. Surgery 1999;126:624-7.
31. Rohde LE, Arroyo LH, Rifai N, CreagerMA, Libby P, Ridker PM, et al.
Plasma concentrations of interleukin-6 and abdominal aortic diameter
among subjects without aortic dilatation. Arterioscler Thromb Vasc
Biol 1999;19:1695-9.
32. Ertel W, Keel M, Steckholzer U, UngethumU, Trentz O. Interleukin-10
attenuates the release of proinflammatory cytokines but depresses
splenocyte functions in murine endotoxemia. Arch Surg 1996;131:
51-6.
33. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10
inhibits metalloproteinase and stimulates TIMP-1 production in human
mononuclear phagocytes. J Clin Invest 1995;96:2304-10.
34. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H,
et al. Cellular localization of matrix metalloproteinases in the abdominal
aortic aneurysm wall. J Vasc Surg 1994;20:814-20.
35. Longo GM, XiongW, Greiner TC, Zhao Y, Fiotti N, Baxter BT.Matrix
metalloproteinases 2 and 9 work in concert to produce aortic aneu-
rysms. J Clin Invest 2002;110:625-32.
36. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias
MP, et al. Neutrophil depletion inhibits experimental abdominal aortic
aneurysm formation. Circulation 2005;112:232-40.Submitted Sep 12, 2006; accepted Nov 5, 2006.
